SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-000220
Filing Date
2023-01-04
Accepted
2023-01-04 07:05:49
Documents
15
Period of Report
2023-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20221228_8k.htm   iXBRL 8-K 27666
2 EXHIBIT 99.1 ex_459558.htm EX-99.1 13439
7 ex_459558img001.jpg GRAPHIC 1967
  Complete submission text file 0001437749-23-000220.txt   185364

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20230104.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230104_def.xml EX-101.DEF 11918
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230104_lab.xml EX-101.LAB 15965
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230104_pre.xml EX-101.PRE 12129
9 EXTRACTED XBRL INSTANCE DOCUMENT arav20221228_8k_htm.xml XML 2655
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 23504338
SIC: 2834 Pharmaceutical Preparations